Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Pulsar Helium Shows Positive Seismic Survey Results for Upcoming Appraisal Well (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:VIV)

Avivagen Announces New 500Kg Order for OxC-beta(TM)

Business Wire October 17, 2023

Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2023

Business Wire September 29, 2023

Avivagen Provides Corporate Updates

Business Wire July 31, 2023

Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta(TM) Livestock Product

Business Wire July 24, 2023

Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2023

Business Wire June 6, 2023

Avivagen Announces Significant Increase in Sales to an Existing Customer

Business Wire May 25, 2023

Avivagen Announces Review of Strategic Alternatives

Business Wire May 18, 2023

Avivagen Announces AGM Results

Business Wire April 19, 2023

Avivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSO

Business Wire March 28, 2023
View More News ››

Opinion & Analysis (TSXV:VIV)

Coverage Initiated on Maker of Antibiotic-Free Supplement for Livestock Feed

Streetwise Reports November 27, 2019

Sales of Antibiotic Alternative for Livestock Feed Accelerate in Asia

Streetwise Reports November 18, 2019

Technical Analyst: As Antibiotic Resistance Rises, So May the Stock of This Livestock Feed Company

Streetwise Reports October 16, 2019

5 Small-Caps on Fund Manager Steve Palmer's Radar Screen

Streetwise Reports March 20, 2019

Large US Market Now Open to Livestock Feed Antibiotic Replacement

Streetwise Reports March 12, 2019

Three Small-Caps on This Fund Manager's List

Streetwise Reports November 1, 2018
View More Opinion ››

Bullboard Posts (TSXV:VIV)

Good Job you bagholders.....Stoneman.....et.al

Avivagen Announces Review of Strategic Alternatives
DrJayser - May 18, 2023

Running on Fumes....HAHAHAHAHA!!!!!!!

 announced “Securities for Services” agreements with Top Meadow Consulting Services Inc. and Mr. Graham Burton, the Company has...
DrJayser - March 29, 2023

The company reported net revenues of $66,039

The company reported net revenues of $66,039 and a comprehensive loss of $(1,153,930) for the three-month period ending Jan. 31, 2023...
DrJayser - March 17, 2023

I told you

Well it seems that all you Geniuses abandoned your beloved Avivgen you're all gone I told you that this piece of s*** was worthless
DrJayser - March 17, 2023

RE:RE:Hope? Nah....

KA should try Ozempic....
DrJayser - January 30, 2023

RE:RE:Merry Christmas

I live you version a lot!
DrJayser - January 20, 2023
View more Bullboard ››

E-Power Resources Inc

E-Power Resources Inc

E-Power Resources Inc. is a Canada-based exploration stage company. The Company is engaged principally in the acquisition ...
View More »